ClinicalTrials.Veeva

Menu

Determination of the Minimal Detectable Change of the Parkinson's Disease Questionnaire-8

E

Emre Şenocak

Status

Enrolling

Conditions

Parkinson Disease

Treatments

Other: Rehabilitation

Study type

Observational

Funder types

Other

Identifiers

NCT06487364
2024/78

Details and patient eligibility

About

This study is conducted to determine how many units of improvement the Parkinson's Disease Questionnaire-8 (PDQ-8), used to evaluate the quality of life of Parkinson's patients, should have to express a significant change in the quality of life. Patients for whom a 30-session physiotherapy program is recommended will be included in the study. Patients will be asked to express the change in their quality of life at the end of treatment. The PDQ-8 survey and Global Rating of Patient-Perceived Changes (GRP-PC) forms will be used to determine these changes. Evaluations will be repeated at the beginning of the treatment program and at the end of the 30th session.

Enrollment

39 estimated patients

Sex

All

Ages

40 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Having regular neurology follow-up and using medicine;
  • Hoehn and Yahr Scale Stage between 1-3 points;
  • Mini-Mental State Assessment Score >24 points;

Exclusion criteria

  • Having a secondary neurological disease;
  • Any surgery and/or trauma affecting the upper extremity
  • Having complaints of pain before the treatment program;
  • There was a change in medical treatment during the study;
  • With symptoms of anxiety and depression;
  • Those who use alcohol and drugs;
  • Individuals with vision defects that cannot be corrected by the use of glasses and those with hearing loss

Trial design

39 participants in 1 patient group

Physiotherapy Group
Description:
There will be only one group in the study. Patients will only be applied to the physiotherapy program recommended by the specialist physician and physiotherapist. It is not possible to apply any additional treatment within the scope of the study.
Treatment:
Other: Rehabilitation

Trial contacts and locations

1

Loading...

Central trial contact

Emre Şenocak, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems